Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
10 2020
Historique:
received: 19 05 2020
revised: 26 08 2020
accepted: 27 08 2020
pubmed: 6 9 2020
medline: 15 4 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

Reconstructive surgery in head and neck cancers frequently involves the use of autologous flaps to improve functional outcomes. However, the literature suggests that postoperative radiotherapy deteriorates functional outcomes due to flap atrophy and fibrosis. Data on patterns of relapse after postoperative radiotherapy with a flap are lacking, resulting in heterogenous delineation of postoperative clinical target volumes (CTV). Flap delineation is unusual in routine practice and there are no guidelines on how to delineate flaps. Therefore, we aim to propose a guideline for flap delineation in head and neck cancers to assess dose-effects more accurately with respect to flaps. Common flaps were selected. They were delineated by radiation oncologists and head and neck surgeons based on operative reports, on contrast-enhanced planning CTs and checked by a radiologist. Each flap was divided into its vascular pedicle and its soft tissue components (fat, fascia/ muscle, skin, bone). Delineation (body and pedicle) of Facial Artery Musculo-Mucosal, pectoralis, radial forearm, anterolateral thigh, fibula and scapula flaps was performed. Based on information provided in operative reports, i.e. tissue components, size and location, flaps can be identified. The various tissue components of each flap can be individualized to facilitate the delineation. This atlas could serve as a guide for the delineation of flaps and may serve to conduct studies evaluating dose-effects, geometric patterns of failure or functional outcomes after reconstructive surgery. Changes in postoperative CTV definitions might be needed to improve risk/benefit ratio in the future based on surgery-induced changes.

Identifiants

pubmed: 32890610
pii: S0167-8140(20)30754-4
doi: 10.1016/j.radonc.2020.08.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-265

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

J Le Guevelou (J)

Department of Radiation Oncology, Centre François Baclesse, Caen, France.

V Bastit (V)

Department of Head and Neck Surgery, Centre François Baclesse, Caen, France.

P Y Marcy (PY)

Department of Radiodiagnostics & Interventional Imaging, ELSAN Group. La Seyne, France.

A Lasne-Cardon (A)

Department of Head and Neck Surgery, Centre François Baclesse, Caen, France.

L Guzene (L)

Department of Radiation Oncology, Amiens Picardie University Medical Center, Amiens, France.

M Gerard (M)

Department of Radiation Oncology, Centre François Baclesse, Caen, France.

A Larnaudie (A)

Department of Radiation Oncology, Centre François Baclesse, Caen, France.

A Coutte (A)

Department of Radiation Oncology, Amiens Picardie University Medical Center, Amiens, France.

A Beddok (A)

Department of Radiation Oncology, Institut Curie, Paris, France.

V Calugaru (V)

Department of Radiation Oncology, Institut Curie, Paris, France.

A Johnson (A)

Department of Medical Oncology, Centre François Baclesse, Caen, France.

B Gery (B)

Department of Radiation Oncology, Centre François Baclesse, Caen, France.

X Liem (X)

Department of Radiation Oncology, Oscar Lambret Center, Lille, France.

Y Pointreau (Y)

Department of Radiation Oncology, Centre Jean Bernard, Le Mans, France.

J Bourhis (J)

Department of Radiation Oncology, CHUV, Lausanne, Switzerland.

J Thariat (J)

Department of Radiation Oncology, Centre François Baclesse, Caen, France; Laboratoire de physique Corpusculaire IN2P3/ENSICAEN - UMR6534, Normandie Université, Caen, France. Electronic address: jthariat@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH